Skip to content
Independent analysis of NHS open data
PharmaInsight

Dolutegravir/Abacavir/Lamivudine vs Entecavir

National NHS prescribing compared (Prescription Cost Analysis)
Data updated April 2026

Entecavir was dispensed 279.0× as often as Dolutegravir/Abacavir/Lamivudine in April 2026 — 279 items versus 1 in England.

1items

Dolutegravir/Abacavir/Lamivudine · April 2026

NHSBSA Prescription Cost Analysis

279items

Entecavir · April 2026

NHSBSA Prescription Cost Analysis

Figure 1. Dolutegravir/Abacavir/Lamivudine versus Entecavir: national items dispensed by month

▬ Dolutegravir/Abacavir/Lamivudine   ·   ╌ Entecavir

0 150 300 Mar 2026 Apr 2026 Entecavir 1 Mar 2026: 1 Apr 2026: 1

Source: NHSBSA Prescription Cost Analysis, to April 2026

Dolutegravir/Abacavir/Lamivudine versus Entecavir, April 2026
Measure Dolutegravir/Abacavir/Lamivudine Entecavir
Items, April 2026 1 279
Items, last 12 months 2 3,325
Net ingredient cost, April 2026 £798 £138,668

See the full profile for Dolutegravir/Abacavir/Lamivudine or Entecavir.